Connection
Toby Trujillo to Fibrinolytic Agents
This is a "connection" page, showing publications Toby Trujillo has written about Fibrinolytic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.649 |
|
|
|
-
Babilonia KM, Golightly LK, Gutman JA, Hassell KL, Kaiser JN, Kiser TH, Klem PM, Trujillo TC. Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization. Clin Appl Thromb Hemost. 2014 Nov; 20(8):799-806.
Score: 0.338
-
Rudd K, Bessada Y, Barnes GD, Bronas UG, Budd AN, Goot T, Montanez NA, Trujillo T. Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement From the American Heart Association. Circulation. 2026 Nov 03; 154(18):e669-e682.
Score: 0.197
-
Trujillo TC, Nolan PE. Unfractionated heparin in acute coronary syndromes: has its time come and gone? Am J Health Syst Pharm. 1998 Nov 15; 55(22):2402-9.
Score: 0.114